FDA Label for Mattifying Tonic Jafra
View Indications, Usage & Precautions
Mattifying Tonic Jafra Product Label
The following document was submitted to the FDA by the labeler of this product Jafra Cosmetics International. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Otc - Active Ingredient
Active Ingredients Purpose
Salicylic Acid 0.5% Acne Treatment
Otc - Purpose
Uses: Treats Acne
Helps prevent new acne pimples
Otc - Keep Out Of Reach Of Children
Keep out of reach of children
Indications & Usage
When using this product
Using other topical acne medication at the same time or immediately following the use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor.
Warnings
Warnings
For external use only.
If swallowed, get medical help or contact a Poison Control Center right away.
Dosage & Administration
Directions
Clean the skin thoroughly before applying.
Cover the entire affected area with a thin layer 1 to 3 times daily.
Avoid contact with eyes
Because excessive drying of the skin may occur, start with 1 application daily, then gradually increase to 2 or 3 times daily if needed or as directed by a doctor.
If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
Inactive Ingredient
Inactive ingredients: Acrylates Copolymer, Benzophenone-4, Butylene Glycol, Diazolidinyl Urea, Fragrance/parfum, Glycerin, Iodopropynyl Butylcarbamate, Kaolin, Propylene Glycol, SD Alcohol 40-B/Alcohol denat., Sodium PCA, Water/Aqua, Zinc Gluconate, Zinc Oxide/CI77947
Package Label.Principal Display Panel
Jafra Mattifying Tonic
Locion Facial Matificante
200 ml 6.7 Fl Oz
* Please review the disclaimer below.